Hanger, Inc. (HNGR)
| Market Cap | 869.28M |
| Revenue (ttm) | 1.02B |
| Net Income (ttm) | 40.87M |
| Shares Out | 38.13M |
| EPS (ttm) | 1.06 |
| PE Ratio | 21.78 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $22.98 |
| Previous Close | $23.51 |
| Change ($) | -0.53 |
| Change (%) | -2.25% |
| Day's Open | 22.96 |
| Day's Range | 22.68 - 23.18 |
| Day's Volume | 102,408 |
| 52-Week Range | 11.58 - 26.70 |
AUSTIN, Texas--(BUSINESS WIRE)--Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced today that members of its management tea...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
Hanger (HNGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Hanger, Inc. (HNGR) CEO Vinit Asar on Q3 2020 Results - Earnings Call Transcript
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
Hanger (HNGR) delivered earnings and revenue surprises of 300.00% and 4.32%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Hanger (HNGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AUSTIN, Texas--(BUSINESS WIRE)--Hanger, Inc. (NYSE: HNGR) today announced the promotion and hiring of two senior executives to lead its two business segments, effective Nov. 2, 2020: Regina We...
AUSTIN, Texas--(BUSINESS WIRE)--Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, today announced it will report its financial resul...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
Hanger (HNGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AUSTIN, Texas--(BUSINESS WIRE)--Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced today that members of its management tea...
Hanger (HNGR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
Hanger's (HNGR) CEO Vinit Asar on Q2 2020 Results - Earnings Call Transcript
Hanger (HNGR) delivered earnings and revenue surprises of 200.00% and 36.25%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
AUSTIN, Texas--(BUSINESS WIRE)--Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for th...
Hanger (HNGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AUSTIN, Texas--(BUSINESS WIRE)--Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, today announced it will report its financial resul...
Hanger, Inc. (HNGR) CEO, Vinit Asar on Q1 2020 Results - Earnings Call Transcript
Hanger (HNGR) delivered earnings and revenue surprises of 17.65% and -3.54%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Hanger's (HNGR) first-quarter 2020 results are likely to reflect strong performance at its Patient Care segment, partially offset by high costs.
Hanger (HNGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hanger (HNGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Hanger (HNGR) CEO, Vinit Asar on Q4 2019 Results - Earnings Call Transcript
Hanger (HNGR) delivered earnings and revenue surprises of 2.27% and 0.06%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Hanger (HNGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rosy Outlook for Outpatient and Home Healthcare Industry
Does Hanger (HNGR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Prominent activities in the healthcare sector are pushing the sector ahead this quarter.
Does Hanger (HNGR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Hanger, Inc. (HNGR) CEO Vinit Asar on Q3 2019 Results - Earnings Call Transcript
Hanger (HNGR) Q3 performance is likely to have benefited from strong demand for Orthotic and Prosthetic services across the board.
Hanger (HNGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hanger (HNGR) closed at $22.84 in the latest trading session, marking a +0.35% move from the prior day.
Hanger (HNGR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Top Ranked Momentum Stocks to Buy for October 4th
Let's consider five stocks with a sizable net profit margin to create a successful portfolio.
Looking beyond profits to a company's cash position will be far more rewarding as this highlights its true financial health.
5 Defensive Stocks to Guard Against Economic Slow Down
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Cash indicates a company's true financial health. It holds the key for its existence, development and success.
Materion (MTRN) and Hanger (HNGR) Are Aggressive Growth Rank Buys
A look at two more stocks for your aggressive growth stock radar screen.
Here's How Investors Can Profit from Stocks Hitting New Highs
Top Ranked Momentum Stocks to Buy for September 5th
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
Hanger, Inc. (HNGR) CEO Vinit Asar on Q2 2019 Results - Earnings Call Transcript
Hanger (HNGR) delivered earnings and revenue surprises of 16.67% and 1.73%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Hanger, Inc. (HNGR) CEO Vinit Asar on Q1 2019 Results - Earnings Call Transcript
Hanger (HNGR) delivered earnings and revenue surprises of -166.67% and -2.87%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
About HNGR
Hanger provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates through two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and provides payor network contractin... [Read more...]
| Industry Medical Care Facilities | Founded 1861 |
| CEO Vinit Asar | Employees 4,800 |
| Stock Exchange NYSE | Ticker Symbol HNGR |
Analyst Forecasts
According to 2 analysts, the average rating for Hanger, Inc. stock is "Buy." The 12-month stock price forecast is 22.50, which is a decrease of -2.09% from the latest price.